The Oxford/AstraZeneca vaccine appears to offer only limited protection against mild disease caused by the South African variant of coronavirus, according to new research. Early data from the study, due to be published on Monday, shows the jab may protect against severe disease caused by the mutation, though data is limited. The study from the